Clinical Trials Browser

Phase 3 × Erlotinib Hydrochloride × Gastrointestinal × Clear all

NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Phase 3 Completed

546 enrolled 29 charts

Gastrointestinal

Pancreatic Intraductal Neoplasms

NCT00026338 2020-04-02

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00040183 2018-01-10

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02694536 2017-03-24

A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Phase 3 Completed

80 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00265824 2015-12-11

DREAM

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00634725 2015-12-11

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01229813 2015-04-13

ACT2

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00686114 2014-04-29

Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer

Phase 3 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT00598156 2013-04-22

ACT

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00440167 2012-07-09

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms